Daclatasvir Dihydrochloride
Ibisobanuro
Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) ni imbaraga kandi ikora mu kanwaPoroteyine ya HCV NS5Ainhibitor hamweEC50s Urutonde rwa 9-146 pM kurigenotypes nyinshi za HCV. Daclatasvir dihydrochloride nayo ni aanion organic itwara polypeptide 1B (OATP1B)naOATP1B3inhibitor hamweIC50s ya 1.5 µM na 3.27 µM, uko bikurikirana.
IC50& Intego
EC50: 50 pM (genotype ya HCV 1a), 9 pM (genotype ya HCV ya 1b), 71 pM HCV ikoporora genotype 5a)[1]
Kd: 8 nM (NS5A33-202) na 210 nM (NS5A26-202)[2]
IC50: 1.5 µM (OATP1B) na 3.27 µM (OATP1B3)[3]
Muri Vitro
Daclatasvir (BMS-790052) yerekana ibikorwa bikomeye byo kubuza genotypes zose zapimwe, hamwe na EC50indangagaciro kuva kuri 9 pM kugeza 146 pM. Daclatasvir ibuza HCV replicon genotype 1a, 1b, 2a, 3a, 4a na 5a hamwe na EC50indangagaciro za 50 pM, 9 pM, 71 pM, 146 pM, 12 pM na 33 pM. Daclatasvir ni inzitizi ikomeye ya virusi ya JFH-1 genotype 2a yandura mu muco w'akagari (EC50= 28 pM)[1]. Daclatasvir (BMS-790052) ihuza cyane na NS5A33-202 na NS5A26-202 hamwe na Kds ya 8 nM na 210 nM[2].
Ububiko
| Ifu | -20 ° C. | Imyaka 3 |
| 4 ° C. | Imyaka 2 | |
| Mubishobora | -80 ° C. | Amezi 6 |
| -20 ° C. | Ukwezi 1 |
Ikigeragezo cya Clinical
| Umubare wa NCT | Umuterankunga | Imiterere | Itariki yo gutangiriraho | Icyiciro |
| NCT03369327 | Ishuri Rikuru ry'Ubuvuzi rya Tehran | Uruganda rukora imiti rwa RojanPharma | Indwara ya Hepatitis C Yanduye, Igisubizo cyo Kuvura | Virusi ya Immunodeficiency ya muntu | Ku ya 1 Mutarama 2017 | Icyiciro cya 3 |
| NCT03485846 | R-Pharm | Almedis | Indwara ya Hepatite idakira C Genotype 1b | Ku ya 27 Ugushyingo 2017 | Icyiciro cya 2 |
| NCT01016912 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2009 | Icyiciro cya 2 |
| NCT01629732 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Werurwe 2013 | Icyiciro cya 2 |
| NCT01497834 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mutarama 2012 | Icyiciro cya 3 |
| NCT01973049 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2013 | Icyiciro cya 3 |
| NCT00663208 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Gicurasi 2008 | Icyiciro cya 2 |
| NCT02576314 | Ikigo cyubushakashatsi bwubuzima nubuzima | Beijing 302 Ibitaro | Indwara ya Hepatite idakira C. | Gicurasi 2015 | Icyiciro cya 3 |
| NCT02756936 | Ikigo Cyukuri Cyubushakashatsi, Misiri | Zeta Pharma Pharmaceutical Industries | Amagara mazima | Gashyantare 2016 | Icyiciro cya 1 |
| NCT02771405 | Ikigo cy'igihugu gishinzwe ubuvuzi bwa Hepatologiya & Tropical Medicine Research Institute | Kaminuza ya Cairo | Indwara ya Hepatite C, karande | Indwara ya Hepatocellular Carcinoma | Werurwe 2016 | Icyiciro cya 3 |
| NCT03706898 | Viriom | VIH-1-kwandura | Ubumuga bwo mu nda | Ku ya 1 Ukwakira 2018 | Icyiciro cya 1 |
| NCT02319031 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Gashyantare 2015 | Icyiciro cya 3 |
| NCT02124044 | Ikigo cyigihugu cyubuzima Clinical Centre (CC) | Ikigo cyigihugu gishinzwe allergie nindwara zanduza (NIAID) | Bristol-Myers Squibb | VIH-HCV | Gashyantare 2014 | Icyiciro cya 2 |
| NCT02551861 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2015 | Icyiciro cya 2 |
| NCT00859053 | Bristol-Myers Squibb | Indwara idahagije | Werurwe 2009 | Icyiciro cya 1 |
| NCT01257204 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Ukuboza 2010 | Icyiciro cya 2 |
| NCT03063879 | Ishuri Rikuru ry’Ubuvuzi rya Tehran | Ahvaz Jundishapur Kaminuza y’Ubuvuzi | Shiraz University of Science Science | Kaminuza y’ubuvuzi ya Hamadan | Indwara ya Hepatite C, idakira | Kunanirwa kw'impyiko zidakira | Ku ya 1 Mata 2017 | Icyiciro cya 4 |
| NCT01017575 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2009 | Icyiciro cya 2 |
| NCT02865369 | Sang Gyune Kim | Ibitaro bya Boramae bya kaminuza nkuru ya Seoul | Ibitaro bya Severance | Ibitaro bya kaminuza ya Inha | Kaminuza ya Koreya | Ikigo cy’ubuvuzi cya kaminuza ya Gachon | Ibitaro bya kaminuza ya Hanyang | Ibitaro bya kaminuza bya Ewha Womans | Ibitaro bya Mokdong | | Indwara ya Hepatite idakira C. | Nzeri 2016 |
|
| NCT04070235 | Nanjing Sanhome Pharmaceutical, Co, Ltd. | Indwara ya Hepatite C, karande | Ku ya 29 Werurwe 2019 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT03487848 | Bristol-Myers Squibb | Indwara ya Hepatite C | Indwara idakira | Ku ya 18 Gicurasi 2018 | Icyiciro cya 2 |
| NCT00904059 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Gicurasi 2009 | Icyiciro cya 1 |
| NCT02107365 | Ikigo cy’igihugu cy’Ubufaransa gishinzwe Ubushakashatsi n’Ubuvuzi-Ikigo cy’igihugu cy’Ubufaransa gishinzwe ubushakashatsi kuri SIDA na Hepatite ya virusi (Inserm-ANRS) | Bristol-Myers Squibb | Hepatitis C Virusi Genotype 4 Kwandura | Ugushyingo 2013 | Icyiciro cya 2 |
| NCT02397395 | Janssen R&D Irlande | Impyiko Zimpyiko | Indwara yanyuma-Indwara Yimpyiko | Gicurasi 2015 | Icyiciro cya 2 |
| NCT03169348 | Kaminuza ya Assiut | Indwara ya Hepatite C. | Ku ya 1 Ugushyingo 2017 | Ntabwo ari ngombwa |
| NCT02323594 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2014 | Icyiciro cya 1 |
| NCT03537196 | Ikigo cy’igihugu cy’Ubufaransa gishinzwe Ubushakashatsi n’Ubuvuzi-Ikigo cy’igihugu cy’Ubufaransa gishinzwe ubushakashatsi kuri SIDA na Hepatite ya virusi (Inserm-ANRS) | Indwara ya Hepatite C | Gukoresha ibiyobyabwenge | Indwara ya Hepatite C. | Ku ya 13 Ugushyingo 2018 | Icyiciro cya 4 |
| NCT02103569 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mata 2014 | Icyiciro cya 1 |
| NCT02772744 | Kaminuza ya Zagazig | Kaminuza ya Cairo | Indwara ya Hepatite C. | Ku ya 1 Ugushyingo 2017 |
|
| NCT01718158 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mutarama 2013 | Icyiciro cya 3 |
| NCT02496078 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Kanama 2015 | Icyiciro cya 3 |
| NCT01425970 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Gicurasi 2012 | Icyiciro cya 2 |
| NCT01471574 | Bristol-Myers Squibb | Indwara ya Hepatite C, Genotype 1 | Ukuboza 2011 | Icyiciro cya 3 |
| NCT01573351 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Gicurasi 2012 | Icyiciro cya 3 |
| NCT01938625 | Janssen R&D Irlande | Indwara ya Hepatite C, karande | Ku ya 12 Ukuboza 2013 | Icyiciro cya 2 |
| NCT01492426 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mutarama 2012 | Icyiciro cya 3 |
| NCT03480932 | Johns Hopkins Bloomberg Ishuri ryubuzima rusange | Ikigo cyigihugu gishinzwe kurwanya ibiyobyabwenge (NIDA) | Ikigo cya YR Gaitonde gishinzwe ubushakashatsi n’uburezi kuri sida | Indwara ya Hepatite C, karande | Ku ya 2 Gashyantare 2018 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT03163849 | Kaminuza ya Assiut | Indwara ya Hepatite idakira c | Ku ya 1 Nzeri 2019 | Icyiciro cya 3 |
| NCT01581203 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Gicurasi 2012 | Icyiciro cya 3 |
| NCT01492504 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ku ya 7 Gashyantare 2012 |
|
| NCT03686722 | Mohamed Raslan | Ain Shams University | Ikigo cy’ubushakashatsi ku biyobyabwenge, Cairo, Misiri | Indwara ya Diyabete, Ubwoko bwa 2 | Hepatite C | Imiti | Ku ya 9 Nzeri 2017 | Icyiciro cya 1 |
| NCT02262728 | Janssen Ubushakashatsi & Iterambere, LLC | Indwara ya Hepatite C, karande | Ku ya 30 Nzeri 2014 | Icyiciro cya 2 |
| NCT02349048 | Janssen Ubushakashatsi & Iterambere, LLC | Virusi ya Hepatite C. | Mutarama 2015 | Icyiciro cya 2 |
| NCT03882307 | Kaminuza ya Assiut | Indwara ya Hepatite C, karande | Gicurasi 2020 | Icyiciro cya mbere |
| NCT02758509 | Parc de Salut Mar. | Indwara ya Hepatite idakira C | Cirrhose | Ku ya 1 Mutarama 2010 |
|
| NCT01795911 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Werurwe 2013 | Icyiciro cya 2 |
| NCT03549832 | Kaminuza ya Assiut | Kaminuza ya Sohag | Kaminuza yo mu majyepfo | HCV | Ku ya 1 Mutarama 2018 | Ntabwo ari ngombwa |
| NCT02161939 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. |
| |
| NCT01309932 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Werurwe 2011 | Icyiciro cya 2 |
| NCT01995266 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ku ya 28 Gashyantare 2014 | Icyiciro cya 3 |
| NCT02640157 | AbbVie | Indwara ya Hepatite idakira C | Virusi ya Hepatite C | Genotype ya 3 Hepatite C. | Ukuboza 2015 | Icyiciro cya 3 |
| NCT02032875 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Werurwe 2014 | Icyiciro cya 3 |
| NCT02624063 | Kaminuza nkuru ya São Paulo | Indwara ya Hepatite C, karande | Ukuboza 2015 | Icyiciro cya 4 |
| NCT00546715 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Ugushyingo 2007 | Icyiciro cya 1 | Icyiciro cya 2 |
| NCT01718145 | Bristol-Myers Squibb | Indwara ya Hepatite C Yanduye | Ugushyingo 2012 | Icyiciro cya 3 |
| NCT01616524 | Bristol-Myers Squibb | Virusi ya Hepatite C (HCV) | Nyakanga 2012 | Icyiciro cya 3 |
| NCT02032901 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mutarama 2014 | Icyiciro cya 3 |
| NCT03540212 | Kaminuza ya Ain Shams | Indwara idakira ya HCV | Ku ya 10 Ukuboza 2017 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT02097966 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. |
| |
| NCT02596880 | Ishuri Rikuru ry'Ubuvuzi rya Tehran | Indwara ya Hepatite C | Cirrhose | Nzeri 2015 | Icyiciro cya 3 |
| NCT04019717 | Atea Pharmaceuticals, Inc. | Indwara ya Hepatite C | Indwara ya Hepatite C, idakira | Indwara ya Hepatite idakira C | Indwara ya Hepatite C | Indwara ya HCV | Ku ya 20 Kamena 2019 | Icyiciro cya 2 |
| NCT02992457 | Kaminuza ya Tanta | Indwara ya Hepatite C. | Mutarama 2015 | Icyiciro cya 4 |
| NCT03547895 | Kaminuza ya Zagazig | Indwara ya Cirrhose | Ku ya 1 Kamena 2015 | Ntabwo ari ngombwa |
| NCT03004625 | Ibitaro by’Urwibutso rwa Kaohsiung Chung-Ho | Ibitaro by’Urwibutso rwa Chang Gung | Ibitaro bya Kaminuza bya Tayiwani | Ibitaro Bikuru by’abasirikare ba Taipei, Tayiwani | Ibitaro bya Kaminuza by’Ubuvuzi mu Bushinwa | Ibitaro bya Kaminuza bya Cheng-Kung | Indwara ya Hepatite C. | Ugushyingo 2016 | Icyiciro cya 3 |
| NCT01051414 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mata 2010 | Icyiciro cya 2 |
| NCT02309450 | Ikigo cy’igihugu cy’Ubufaransa gishinzwe Ubushakashatsi n’Ubuvuzi-Ikigo cy’igihugu cy’Ubufaransa gishinzwe ubushakashatsi kuri SIDA na Hepatite ya virusi (Inserm-ANRS) | Bristol-Myers Squibb | Hepatitis C Virusi Genotype 4 Kwandura | Ukuboza 2014 | Icyiciro cya 2 |
| NCT01628692 | Bristol-Myers Squibb | Janssen Ubushakashatsi & Iterambere, LLC | Virusi ya Hepatite C. | Nyakanga 2012 | Icyiciro cya 2 |
| NCT03186313 | Ibitaro byumwijima byo muri Egiputa | Ibitaro bya Wadi El Nil | Indwara ya Hepatite C. | Nzeri 2016 | Icyiciro cya 3 |
| NCT03063723 | Ibitaro bya gatatu bishamikiye kuri kaminuza, Sun Yat-Sen | Indwara ya Hepatite idakira C (Disorder) | Ku ya 1 Mutarama 2016 |
|
| NCT00983957 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Ukwakira 2009 | Icyiciro cya 1 |
| NCT01725542 | Ikigo cy’igihugu cy’Ubufaransa gishinzwe Ubushakashatsi n’Ubuvuzi-Ikigo cy’igihugu cy’Ubufaransa gishinzwe ubushakashatsi kuri SIDA na Hepatite ya virusi (Inserm-ANRS) | Bristol-Myers Squibb | Kwandura HCV-VIH | Ukuboza 2012 | Icyiciro cya 2 |
| NCT02282709 | Urufatiro rwubushakashatsi bwumwijima | Indwara ya Hepatite idakira C. | Gashyantare 2014 | Icyiciro cya 3 |
| NCT02032888 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Gashyantare 2014 | Icyiciro cya 3 |
| NCT03247296 | Kaminuza ya MTI | Indwara ya Hepatite C. | Ku ya 28 Gashyantare 2017 |
|
| NCT01389323 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Nzeri 2011 | Icyiciro cya 3 |
| NCT02556086 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2015 | Icyiciro cya 2 |
| NCT01741545 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Ku ya 31 Werurwe 2013 | Icyiciro cya 3 |
| NCT01866930 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Ku ya 11 Nyakanga 2013 | Icyiciro cya 3 |
| NCT02268864 | Janssen-Cilag Mpuzamahanga NV | Indwara ya Hepatite C, karande | Mutarama 2015 | Icyiciro cya 2 |
| NCT01797848 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Kamena 2014 | Icyiciro cya 3 |
| NCT03166280 | Eman Sayed Hassan Abd Allah | Kaminuza ya Assiut | Indwara ya Hepatite C. | Kamena 2017 |
|
| NCT02159352 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Kamena 2014 | Icyiciro cya 1 |
| NCT01125189 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Nyakanga 2010 | Icyiciro cya 2 |
| NCT03748745 | Nanjing Sanhome Pharmaceutical, Co, Ltd. | Imikoreshereze yibiyobyabwenge | Ku ya 19 Ugushyingo 2018 | Icyiciro cya 1 |
| NCT01012895 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Ukuboza 2009 | Icyiciro cya 2 |
| NCT02565888 | Kaminuza ya Radboud | Indwara ya Hepatite C | VIH | Ugushyingo 2015 | Icyiciro cya 1 |
| NCT02555943 | Ikigo cyubushakashatsi bwubuzima nubuzima | Beijing 302 Ibitaro | Ibitaro bya Nanfang bya kaminuza yubuvuzi bwamajyepfo | Indwara ya Hepatite idakira C | HBV Coinfection | Hepatitis B Reactivation | Gashyantare 2015 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT02304159 | Tarek I. Hassanein, MD, FACP, FAG, AGAF | Ikigo cy’ubushakashatsi cy’amajyepfo ya California | Indwara ya Hepatite C | Cirrhose | Mutarama 2015 | Icyiciro cya 4 |
| NCT02580474 | Indirimbo ya Myeong Jun | Bristol-Myers Squibb | Ibitaro bya Kaminuza ya Soonchunhyang | Kaminuza ya Dankook | Ibitaro bya Kaminuza bya Chungnam | Ibitaro bya Koniang | Ibitaro bya Kaminuza bya Eulji | Ibitaro bya Saint Vincent´s, Koreya | Ibitaro bya Kaminuza bya Konkuk | Ibitaro bya Cheongju Mutagatifu Mary´s, Cheongju , Koreya | Ibitaro bya Severance | Ibitaro bya kaminuza ya Koreya ya Guro | Ibitaro Bikuru bya Eulji | Kaminuza Gatolika ya Koreya | Indwara ya Hepatite C. | Gashyantare 2016 | Icyiciro cya 4 |
| NCT02104843 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Mata 2014 | Icyiciro cya 1 |
| NCT01428063 | Bristol-Myers Squibb | Indwara ya Hepatite C Yanduye | Nzeri 2011 | Icyiciro cya 2 |
| NCT02123654 | Bristol-Myers Squibb | Indwara ya Hepatite C Yanduye | Mata 2014 | Icyiciro cya 3 |
| NCT02565862 | Kaminuza ya Radboud | Hepatite C | Diyabete Mellitus | Kurwanya insuline | Mutarama 2016 | Icyiciro cya 1 |
| NCT04211844 | Kaminuza ya Ain Shams | Indwara ya Hepatite idakira C. | Ku ya 1 Ukwakira 2019 |
|
| NCT00874770 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Kamena 2009 | Icyiciro cya 2 |
| NCT03883698 | Sanjay Gandhi Postgraduate Institute of Medical Science | Kunanirwa kw'impyiko, karande | Hepatite C. | Ku ya 15 Werurwe 2019 | Icyiciro cya 3 |
| NCT01448044 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Ukuboza 2011 | Icyiciro cya 3 |
| NCT01359644 | Bristol-Myers Squibb | Pharmasset | Indwara ya Hepatite idakira C. | Kamena 2011 | Icyiciro cya 2 |
| NCT01842451 | Imiti ya Vertex Yashizwemo | Indwara ya Hepatite idakira C | CHC | HCV | Indwara ya Hepatite C. | Kamena 2013 | Icyiciro cya 2 |
| NCT02762448 | Ibitaro bya Komini ya Tainan | Indwara ya Hepatite c | Nyakanga 2016 |
|
| NCT02473211 | Ikigo cyubushakashatsi bwubuzima nubuzima | Beijing 302 Ibitaro | Indwara ya Hepatite idakira C. | Mutarama 2015 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT01455090 | Bristol-Myers Squibb | Indwara ya Hepatite idakira C. | Ku ya 30 Ugushyingo 2011 | Icyiciro cya 2 |
| NCT03490097 | Kaminuza ya Ain Shams | Indwara ya Hepatite idakira c | Indwara ya Metabolic | Ku ya 1 Ukuboza 2017 | Icyiciro cya 2 | Icyiciro cya 3 |
| NCT01170962 | Bristol-Myers Squibb | Virusi ya Hepatite C. | Kanama 2010 | Icyiciro cya 2 |
| NCT02333292 | Ibitaro bya Kaminuza bya Valme | Ibitaro del SAS de Jerez | Ibitaro Bikuru bya Universitario Elche | Ibitaro La Línea de la Concepción | Complexo Hospitalario Universitario de A Coruña | Ibitaro de Figueres | Ibitaro Universitario Puerto Real | Ibitaro Universitario Virgen de la Victoria | Ibitaro Universitario de Canarias | Ibitaro Bikuru Universitario de Alicante | Ibitaro Universitario Araba | Ibitaro Royo Vilanova | Ibitaro Universitario de Burgos | Complejo Hospitalario Universitario de Huelva | Ibitaro Universitario Reina Sofia de Cordoba | Ibitaro Universitario Virgen Macarena | Complexo Hospitalario Universitario de Vigo | Clinica Universidad de Navarra, Universidad de Navarra | Ibitaro Clinico Universitario San Cecilio | Universitario de Valencia | Ibitaro Universitario Infanta Leonor | Ibitaro Universitario de Gran Canaria | Ibitaro Bikuru Universitario Santa Lucía | Centro Penitenciario Alicante 1 | Ibitaro byo mu karere Universitario Carlos Haya | Ibitaro Virgen de la Luz | Ibitaro Bikuru bya Universitario de Castellón | Ibitaro Parc Taulí, Sabadell | Indwara ya Hepatite idakira C. | Ukuboza 2014 |
|
| NCT03200184 | Ishuri Rikuru ry'Ubuvuzi rya Tehran | Indwara ya Hepatite C. | Ku ya 1 Nzeri 2016 | Icyiciro cya 4 |
| NCT03188276 | Ibitaro bya gatatu bishamikiye kuri kaminuza, Sun Yat-Sen | Indwara ya Hepatite idakira C. | Ku ya 1 Gashyantare 2016 | Icyiciro cya mbere |
| NCT01830205 | Bristol-Myers Squibb | Indwara ya Hepatite C. | Nzeri 2012 | Icyiciro cya 1 |
Icyifuzo18Imishinga yo gusuzuma ireme ryiza yemejwe4, na6imishinga iremezwa.
Sisitemu mpuzamahanga yo gucunga neza ubuziranenge yashyizeho urufatiro rukomeye rwo kugurisha.
Igenzura ryiza rinyura mubuzima bwose bwibicuruzwa kugirango hamenyekane ingaruka nziza nubuvuzi.
Itsinda rishinzwe kugenzura ibikorwa byumwuga rishyigikira ubuziranenge busabwa mugihe cyo gusaba no kwiyandikisha.
Koreya Countec Amacupa yo gupakira
Tayiwani CVC Icupa ryuzuye
Ubutaliyani CAM Ubuyobozi bwo gupakira
Imashini yo Kudage Fette
Ubuyapani Viswill Tablet Detector
Icyumba cyo kugenzura DCS
Ubufatanye mpuzamahanga
Ubufatanye mu gihugu
Andika ubutumwa bwawe hano hanyuma utwohereze
